Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / Spain

Research and Innovation Action · Running

SYNTHIA Synthetic Data Generation Framework for Integrated Validation of Use Cases and AI Healthcare Applications

Coordinator
Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad Valenciana, Spain
Runs
1 September 2024 to 31 August 2029
Status
Running
EU funding
€12.4m
Total cost
€22.4m
Partners
39 organisations in 17 countries
Type
Research and Innovation Action
Grant agreement
101172872

What the project is doing

In the project's own words, from its summary on CORDIS.

SYNTHIA is an ambitious collaboration between public and private institutions to facilitate the responsible use of Synthetic Data (SD) in healthcare applications. The project will improve the methodological and technical aspects of SD Generation (SDG) by developing new techniques and advancing established ones for different data modalities, including genomics and imaging, to improve the generation of realistic multimodal and longitudinal data.

This project will provide the research community with approaches for transparent benchmarking of alternative SDG methods for specific applications, identify and establish evaluation metrics and methodologies, and contribute to the standardisation of an evaluation assessment framework for SD. Robust evidence of SD applicability in a set of use cases across a broad spectrum of medical conditions will be crucial to demonstrate the potential of SD to accelerate data-driven solutions of equivalent quality to those derived from real patient data.

Furthermore, legal and regulatory implications of SD use will be analysed with the aim of delivering an assurance framework to guide secure SD utilization in healthcare. These significant breakthroughs will be implemented through the open SYNTHIA federated platform, facilitating responsible SD use by the health research community. The platform will facilitate users´ long-term access to extensively validated, reusable synthetic datasets, as well as to SDG workflows and SD assessment frameworks.

The federated infrastructure will rely on extended open-source frameworks for interoperability with other data-sharing infrastructures in the context of the European Health Data Space. A multidisciplinary collaboration of SDG developers, FAIR data experts, clinical researchers, developers of therapies and data-based tools, legal experts, socio-economic analysts, regulatory, policy advocacy, and communication experts will provide a 360º vision on how to advance healthcare applications through SD use.

Topics

Who is involved

OrganisationCityCountryRole
Fundacion Para La Investigacion Del Hospital Universitario La Fe De La Comunidad ValencianaValenciaSpainCoordinator
Universitat WienWienAustriaParticipant
European Alliance for Personalised Medicine ASBLBruxelles / BrusselBelgiumParticipant
Janssen Pharmaceutica NVBeerseBelgiumParticipant
The European Institute for Innovation Through Health DataGentbruggeBelgiumParticipant
Centre Hospitalier Universitaire VaudoisLausanneSwitzerlandAssociatedpartner
Charite - Universitaetsmedizin BerlinBerlinGermanyParticipant
European Molecular Biology LaboratoryHeidelbergGermanyParticipant
Fraunhofer Gesellschaft Zur Forderung Der Angewandten Forschung eVMunchenGermanyParticipant
Ge Healthcare GmbHDusseldorfGermanyThird party
Patvocates GmbHRiemerlingGermanyParticipant
Pfizer Pharma GmbHBerlinGermanyAssociatedpartner
Novo Nordisk A/sBagsvaerdDenmarkParticipant
Ethniko Kentro Erevnas Kai Technologikis AnaptyxisThermi ThessalonikiGreeceParticipant
Barcelona Supercomputing Center Centro Nacional De SupercomputacionBarcelonaSpainParticipant
Fundacio Hospital Universitari Vall D'hebron - Institut De RecercaBarcelonaSpainParticipant
Fundacio Privada Institut D'investigacio Oncologica De Vall-Hebron (vhio)BarcelonaSpainParticipant
General Electric Healthcare Espana SAMadridSpainThird party
Matical Innovation SLMadridSpainParticipant
Universidad Politecnica De MadridMadridSpainParticipant
Hus-YhtymaHelsinkiFinlandParticipant
Ge Medical Systems ScsBucFranceParticipant
Ge Healthcare Magyarorszag KftBudapestHungaryThird party
Wipro GE Healthcare Private Ltd.KadugodiIndiaAssociatedpartner
Alma Mater Studiorum - Universita Di BolognaBolognaItalyParticipant
Azienda Unita' Sanitaria Locale Di BolognaBolognaItalyThird party
Humanitas Mirasole SpARozzano (Mi)ItalyParticipant
Irccs Azienda Ospedaliero- Universitaria Di BolognaBolognaItalyThird party
Train SRLRozzanoItalyParticipant
Information Technology for Translational Medicine (ittm) SAEsch-UelzechtLuxembourgParticipant
Academisch Ziekenhuis LeidenLeidenNetherlandsParticipant
Erasmus Universitair Medisch Centrum RotterdamRotterdamNetherlandsParticipant
Dnv ASHovikNorwayParticipant
Ge Healthcare LimitedChalfont St GilesUnited KingdomAssociatedpartner
National Institute for Health and Care ExcellenceManchesterUnited KingdomAssociatedpartner
Bristol-Myers Squibb Company CorpNew YorkUnited StatesParticipant
Gates Ventures LlcKirklandUnited StatesParticipant
GE Healthcare IITS USA Corp.ChicagoUnited StatesAssociatedpartner
Pfizer IncNew York CityUnited StatesParticipant

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI